Estimation of the frequency of self-reactive T cells in health and inflammatory diseases by limiting dilution analysis and single cell cloning

Journal of Autoimmunity

Volumn 9, Issue 5, 1996, Pages 667-675

  Lohse, Ansgar W ^a   Dinkelmann, Matthias ^a   Kimmig, Martin ^a   Herkel, Johannes ^a   Meyer Zum Büschenfelde, Karl Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Autoimmunity; Autoreactive T cells; Hepatitis; IL 2; Limiting dilution analysis

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0030271685     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0087     Document Type: Article

References (38)

1. 1. Burnet F.M. 1959. The clonal selection theory of acquired immunity. Nashville: Vanderbilt University Press
2. 2. Kisielow P., Blüthmann H., Staerz U.D., Steinmetz M., von Boehmer H. 1988. Tolerance in T-cell receptor transgenic mice involves deletion of nonmature CD4+8+thymocytes. Nature 333: 742-746
3. 3. von Boehmer H., Kisielow P. 1993. Lymphocyte lineage commitment: instruction versus selection. Cell 73: 207-208
4. 4. Ferber I., Schönrich G., Schenkel J., Mellor A.L., Hämmerling G.J., Arnold B. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263: 674-676
5. 5. Arnold B., Schönrich G., Hämmerling G.J. 1993. Multiple levels of peripheral tolerance. Immunol Today 14: 12-14
6. 6. Kroemer G., Martinez-AC. 1991. The fail-safe paradigm of immunological self-tolerance. Lancet 338: 1246-1249
7. 7. Guilbert B., Dighiero G., Avrameas S. 1982. Naturally occurring antibodies against nine common antigens in normal humans. I. Detection isolation, and characterization. J. Immunol. 28: 2779-2787
8. 8. Holmberg D., Coutinho A. 1985. Natural antibodies and autoimmunity. Immunol. Today 6: 356-357
9. 9. Cohen I.R., Cooke A. 1986. Natural autoantibodies might prevent autoimmune disease. Immunol. Today 7: 363-364
10. 10. Avrameas S. 1991. Natural autoantibodies: from "horror autotoxicus" to "gnothi seauton". Immunol. Today 12: 154-159
11. 11. Coutinho A., Kazachkine M.D., Avrameas S. 1995. Natural autoantibodies. Curr. Opin. Immunol. 7: 812-818
12. 12. Mouthon L., Haury M., Lacroix-Desmazes S., Barreau C., Coutinho A., Katzachkine M.D. 1995. Analysis of the normal human IgG antibody repertoire. Evidence that IgG autoantibodies of healthy adults recognize a limited and conserved set of protein antigens in homologous tissues. J. Immunol. 154: 5769-5778
13. 13. Lacroix-Desmazes S., Mouthon L., Coutinho A., Katzachkine M.D. 1995. Analysis of the natural human IgG repertoire; life long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur. J. Immunol. 25: 2598-2604
14. 14. Cohen I.R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today 13: 490-494
15. 15. Moiola L., Karachunski P., Protti M.P., Howard J.F., Conti-Tronconi B.M. 1994. Epitopes on the β subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects. J. Clin. Invest. 93: 1020-1028
16. 16. Barker R.N., Elson C.J. 1994. Multiple self-epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells. Eur. J. Immunol. 24: 1578-1582
17. 17. Pette M., Fujita K., Wilkinson D., et al. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87: 7968-7972
18. 18. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346 : 183-187
19. 19. Martin R., Jaraquemada D., Flerlage M., et al. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145: 540-548
20. 20. Lider O., Reshef T., Beraud E., Ben-Nun A., Cohen I.R. 1988. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 239: 181-183
21. 21. Lohse A.W., Mor F., Karin N., Cohen I.R. 1989. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244: 820-822
22. 22. Lohse A.W., Spahn T.W., Wölfel T., Herkel J., Cohen I.R., Meyer zum Büschenfelde K. H. 1993. Induction of the anti-ergotypic response. Int. Immunol. 5: 533-539
23. 23. Yuen M.H., Protti M.P., Diethelm-Okita B., Moiola L., Howard J.F., Conti-Fine B.M. 1995. Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls. J. Immunol. 154: 1508-1520
24. 24. Pereira P., Forni L., Larsson E.-L., Cooper M., Heusser C., Coutinho A. 1986. Autonomous activation of B and T cells in antigen-free mice. Eur. J. Immunol. 16: 685-688
25. 25. Rötzschke O., Falk K. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol. 6: 45-51
26. 26. Mor F., Cohen I.R. 1992. T cells in the lesion of experimental autoimmune encephalomyelitis. J. Clin. Invest. 90: 2447-2455
27. 27. Taswell C. 1981. Limiting dilution analysis of human T cells: a useful clinical tool. J. Immunol. 126: 1614-1619
28. 28. Huber C., Merkkenschlager M., Gattringer C., Royston I., Fink U., Braunsteiner H. 1982. Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes. J. Exp. Med. 156: 1222-1227
29. 29. Larsson E.-L., Andersson J., Coutinho A. 1978. Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors. Eur. J. Immunol. 8: 693-696
30. 30. Best W.R., Becktel J.M., Singleton J.W., Kern F. 1976. Development of a Crohn's disease activity index. National Cooperative Crohn's disease study. Gastroenterology 70: 439-444
31. 31. Kalish R.S., Johnson K.L. 1990. Enrichment and function of urushiol (poison IVY)-specific T lymphocytes in lesions of allergic contact dermatitis. J. Immunol. 145: 3706-3713
32. 32. Kalish R.S., Johnson K.L., Hordinsky M.K. 1992. Alopecia areata - autoreactive T cells are variably enriched in scalp lesions relative to peripheral blood. Arch. Derm. 128: 1072-1077
33. 33. Schlesier M., Haas G., Wolff-Vorbeck G., Melchers I., Peter H.H. 1989. Autoreactive T cells in rheumatic disease (1). Analysis of growth frequencies and autoreactivity of T cells in patients with rheumatoid arthritis and lyme disease. J. Autoimmun. 2: 31-49
34. 34. Deusch K., Moebius U., Meyer zum Büschenfelde K.H., Meuer S.C. 1986. T lymphocyte control of autoreactivity: analysis with human T cell clones and limiting dilution culture. Eur. J. Immunol. 16: 1433-1438
35. 35. Zhang B.J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. 1994. Increased frequency of interleukin-2-responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179: 973-984
36. 36. Filion M.C., Bradley A.J., Devine D.V., Decary F., Chartand P. 1995. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur. J. Immunol. 25: 3123-3127
37. 37. Cohen I.R. 1992. The cognitive principle challenges clonal selection. Immunol Today 13: 441-444
38. 38. Lohse A.W. 1989. Autoreactive T cells. Curr. Opin. Immunol. 1: 718-726